These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22702656)

  • 1. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
    Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
    Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study.
    Ahlehoff O; Skov L; Gislason G; Lindhardsen J; Kristensen SL; Iversen L; Lasthein S; Gniadecki R; Dam TN; Torp-Pedersen C; Hansen PR
    J Intern Med; 2013 Feb; 273(2):197-204. PubMed ID: 22963528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
    Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
    Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
    J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.
    Abuabara K; Lee H; Kimball AB
    Br J Dermatol; 2011 Nov; 165(5):1066-73. PubMed ID: 21777216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
    Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.
    Shapiro J; Cohen AD; Weitzman D; Tal R; David M
    J Am Acad Dermatol; 2012 Feb; 66(2):252-8. PubMed ID: 21742411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
    Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
    Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of arrhythmia in patients with psoriatic disease: A nationwide population-based matched cohort study.
    Chiu HY; Chang WL; Huang WF; Wen YW; Tsai YW; Tsai TF
    J Am Acad Dermatol; 2015 Sep; 73(3):429-38. PubMed ID: 26188627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
    Boehncke S; Salgo R; Garbaraviciene J; Beschmann H; Hardt K; Diehl S; Fichtlscherer S; Thaçi D; Boehncke WH
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1187-93. PubMed ID: 21241371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood-onset psoriasis: association with future cardiovascular and metabolic comorbidities.
    Mahé E; Maccari F; Beauchet A; Lahfa M; Barthelemy H; Reguiaï Z; Beneton N; Estève E; Chaby G; Ruer-Mulard M; Steiner HG; Pauwels C; Avenel-Audran M; Goujon-Henry C; Descamps V; Begon E; Sigal ML;
    Br J Dermatol; 2013 Oct; 169(4):889-95. PubMed ID: 23937622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
    Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
    Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
    Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
    Kaye JA; Li L; Jick SS
    Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis.
    Ahdout J; Kotlerman J; Elashoff D; Kim J; Chiu MW
    Clin Exp Dermatol; 2012 Jul; 37(5):477-83. PubMed ID: 22712856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.